Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating

被引:397
作者
Cheung, King-Ho [1 ]
Shineman, Diana [2 ,4 ]
Mueller, Marioly [1 ]
Cardenas, Cesar [3 ]
Mei, Lijuan [1 ]
Yang, Jun [1 ]
Tomita, Taisuke [5 ]
Iwatsubo, Takeshi [5 ]
Lee, Virginia M. -Y. [2 ,4 ]
Foskett, J. Kevin [1 ,3 ]
机构
[1] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA
[4] Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA
[5] Univ Tokyo, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan
关键词
D O I
10.1016/j.neuron.2008.04.015
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mutations in presenilins (PS) are the major cause of familial Alzheimer's disease (FAD) and have been associated with calcium (Ca2+) signaling abnormalities. Here, we demonstrate that FAD mutant PS1 (M146L) and PS2 (N141I) interact with the inositol 1,4,5-trisphosphate receptor (InSP3R) Ca2+ release channel and exert profound stimulatory effects on its gating activity in response to saturating and suboptimal levels of InsP(3). These interactions result in exaggerated cellular Ca2+, signaling in response to agonist stimulation as well as enhanced low-level Ca2+, signaling in unstimulated cells. Parallel studies in InSP3R-expressing and -deficient cells revealed that enhanced Ca2+ release from the endoplasmic reticulum as a result of the specific interaction of PS1-M146L with the InSP3R stimulates amyloid beta processing, an important feature of AD pathology. These observations provide molecular insights into the "Ca2+ dysregulation" hypothesis of AD pathogenesis and suggest novel targets for therapeutic intervention.
引用
收藏
页码:871 / 883
页数:13
相关论文
共 67 条
[1]   Cardiac energy metabolism homeostasis: Role of cytosolic calcium [J].
Balaban, RS .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (10) :1259-1271
[2]   Functional phonotype in transgenic mice expressing mutant human presenilin-1 [J].
Barrow, PA ;
Empson, RM ;
Gladwell, SJ ;
Anderson, CM ;
Killick, R ;
Yu, X ;
Jefferys, JGR ;
Duff, K .
NEUROBIOLOGY OF DISEASE, 2000, 7 (02) :119-126
[3]   The versatility and universality of calcium signalling [J].
Berridge, MJ ;
Lipp, P ;
Bootman, MD .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2000, 1 (01) :11-21
[4]   Alzheimer's disease [J].
Blennow, Kaj ;
de Leon, Mony J. ;
Zetterberg, Henrik .
LANCET, 2006, 368 (9533) :387-403
[5]   Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory [J].
Buckner, RL ;
Snyder, AZ ;
Shannon, BJ ;
LaRossa, G ;
Sachs, R ;
Fotenos, AF ;
Sheline, YI ;
Klunk, WE ;
Mathis, CA ;
Morris, JC ;
Mintun, MA .
JOURNAL OF NEUROSCIENCE, 2005, 25 (34) :7709-7717
[6]   CALCIUM REGULATES PROCESSING OF THE ALZHEIMER AMYLOID PROTEIN-PRECURSOR IN A PROTEIN-KINASE C-INDEPENDENT MANNER [J].
BUXBAUM, JD ;
RUEFLI, AA ;
PARKER, CA ;
CYPESS, AM ;
GREENGARD, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4489-4493
[7]   Activity-dependent expression of inositol 1,4,5-trisphosphate receptor type 1 in hippocampal neurons [J].
Cai, WH ;
Hisatsune, C ;
Nakamura, K ;
Nakamura, T ;
Inoue, T ;
Mikoshiba, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (22) :23691-23698
[8]   The presenilin 1 ΔE9 mutation gives enhanced basal phospholipase C activity and a resultant increase in intracellular calcium concentrations [J].
Cedazo-Mínguez, A ;
Popescu, BO ;
Ankarcrona, M ;
Nishimura, T ;
Cowburn, RF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (39) :36646-36655
[9]   Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons [J].
Chan, SL ;
Mayne, M ;
Holden, CP ;
Geiger, JD ;
Mattson, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (24) :18195-18200
[10]   Synaptic activity regulates interstitial fluid amyloid-β levels in vivo [J].
Cirrito, JR ;
Yamada, KA ;
Finn, MB ;
Sloviter, RS ;
Bales, KR ;
May, PC ;
Schoepp, DD ;
Paul, SM ;
Mennerick, S ;
Holtzman, DM .
NEURON, 2005, 48 (06) :913-922